Historical Stock Price
ETFs Holding ORPN »    ORPN Split History »



Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
03/19/2019 $11.18 $11.18 $10.71 $10.85 9.50K
03/20/2019 $10.49 $11.20 $10.49 $11.20 8.70K
03/21/2019 $11.15 $11.74 $10.81 $11.35 10.20K
03/22/2019 $11.49 $11.50 $10.78 $10.78 3.00K
03/25/2019 $10.82 $11.50 $10.32 $11.50 19.80K
Enlivex Therapeutics is a development stage biopharmaceutical company focused on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases. Co. seeks to identify therapeutic platforms that offer solutions for several diseases that share a common pathophysiological mechanism, which are the functional changes that accompany a particular syndrome or disease. Co.'s pipeline is based on three platforms, which are Protein Stabilizing Platform, Read-through Platform and Mitochondrial Protein Replacement Platform.
ORPN historical stock prices picture
ORPN (ORPN) has the following price history information. Looking back at ORPN historical stock prices for the last five trading days, on March 19, 2019, ORPN opened at $11.18, traded as high as $11.18 and as low as $10.71, and closed at $10.85. Trading volume was a total of 9.50K shares. On March 20, 2019, ORPN opened at $10.49, traded as high as $11.20 and as low as $10.49, and closed at $11.20. Trading volume was a total of 8.70K shares. On March 21, 2019, ORPN opened at $11.15, traded as high as $11.74 and as low as $10.81, and closed at $11.35. Trading volume was a total of 10.20K shares. On March 22, 2019, ORPN opened at $11.49, traded as high as $11.50 and as low as $10.78, and closed at $10.78. Trading volume was a total of 3.00K shares. On March 25, 2019, ORPN opened at $10.82, traded as high as $11.50 and as low as $10.32, and closed at $11.50. Trading volume was a total of 19.80K shares.

ORPN Historical Stock Prices By Date:

ORPN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ORPN shares, starting with a $10,000 purchase of ORPN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/31/2014
End date: 03/25/2019
Start price/share: $42.00
End price/share: $11.50
Dividends collected/share: $0.00
Total return: -72.62%
Average Annual Total Return: -24.30%
Starting investment: $10,000.00
Ending investment: $2,738.72
Years: 4.65
Date Close
03/19/2019$10.85
03/20/2019$11.20
03/21/2019$11.35
03/22/2019$10.78
03/25/2019$11.50

ORPN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.